Clinical trials: Granulomatous Slack Skin
Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I
Mechlorethamine Induced Contact Dermatitis Avoidance Study
This is a two-arm, open-label study that aims to compare the incidence and severity of the most common adverse reactions, particularly contact dermatitis, when Valchlor is used alone or in conjunction with triamcinolone ointment…
- Conditions
- Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I, Mycosis Fungoides, Folliculotropic Mycosis Fungoides
- Trial name
- MIDAS (NCT03380026)
- Testing
- Triamcinolone, Valchlor 0.016 % Topical Gel
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Rochester Skin Lymphoma Medical Group, PLLC